Gene tech­no­logy brings more pre­cise in­for­ma­tion on the causes of dia­betes

September 13, 2018, University of Helsinki
Stem cell-derived islet-like aggregate whole-mount immunofluorescence for insulin (red), glucagon (green) and nuclear DNA (blue). Credit: Diego Balboa

The main cause of all forms of diabetes is pancreatic beta-cell dysfunction. Beta cells, found in the pancreatic islets, store and release insulin. Decades of research with animal and cellular models have expanded the knowledge on the molecular mechanisms causing the beta-cells to dysfunction. Diego Balboa's doctoral research now offers a more precise model that employs human pluripotent stem cells.

"Human pluripotent stem cells constitute a renewable source of beta-cells. Stem cell-derived beta-cells can be generated by directed differentiation and used as a model to study pancreatic beta-cell development and disease in vitro," Balboa explains.

Compared to the novel method, the traditionally used animal and cellular models have limitations that may significantly affect the way the findings can be translated into new approaches to combat diabetes in humans. For example, rodent pancreatic islet development and physiology differ from that of humans, and rodent and human insulinoma cell lines do not recapitulate faithfully the functionality of adult human beta-cells.

Thus far, the best model has been the cadaveric donor human islets that are scarce, and difficult to manipulate for certain experiments.

Balboa's research demonstrated the use of human as a tool to investigate monogenic diabetes disease mechanisms. The cells can also be transplanted into immunocompromised mice, generating humanized models where in vivo beta-cell function can be closely evaluated in a systemic context.

"For this purpose, improved human differentiation protocols to the beta-cell lineage were generated utilizing 3-D suspension culture approaches," Balboa says.

In his research, Balboa also established novel CRISPR-Cas9-based gene editing techniques to model monogenic diabetes cases.

"Using these approaches, an activating mutation in STAT3 gene was found to cause neonatal by inducing pancreas endocrinogenesis prematurely. In a similar way, INS gene mutations causing proinsulin misfolding were found to impair developing beta-cell proliferation due to increased endoplasmic reticulum stress."

Explore further: Premature cell differentiation leads to disorders in pancreatic development

Related Stories

Premature cell differentiation leads to disorders in pancreatic development

April 11, 2017
Researchers at the University of Helsinki, Finland, have uncovered a mechanism through which a mutation in the STAT3 gene leads to a disorder in the development of the pancreas and to infant diabetes.

The relevance of GABA for diabetes highlighted in two new studies

April 5, 2018
Dynamic interactions between the nervous system, hormones and the immune system are normally ongoing, but in diabetes the balance is disturbed. Two studies published in EBioMedicine by an international research team from ...

Growing pancreatic stem cells for research on diabetes

November 29, 2017
A new cell culture procedure developed by A*STAR will assist the study of diabetes and facilitate better treatments. "Our discovery will enable studies of how the pancreas forms and why certain cells malfunction in diabetes," ...

Genetic mutation during embryonic development could hold the key to a lifetime living with diabetes

August 24, 2016
Personalized treatment for people with diabetes could be a step closer after researchers discovered how a single gene mutation fundamentally alters pancreatic development.

No rebirth for insulin secreting pancreatic beta cells

April 24, 2013
Pancreatic beta cells store and release insulin, the hormone responsible for stimulating cells to convert glucose to energy. The number of beta cells in the pancreas increases in response to greater demand for insulin or ...

Recommended for you

Diabetes drug might also ease heart failure risks

November 12, 2018
(HealthDay)—The diabetes drug Farxiga might do double-duty for patients, helping to ward off another killer, heart failure, new research shows.

Diabetic foot ulcers heal quickly with nitric oxide technology

November 12, 2018
Diabetic foot ulcers can take up to 150 days to heal. A biomedical engineering team wants to reduce it to 21 days.

Marijuana use tied to serious diabetes complication

November 8, 2018
(HealthDay)—People with type 1 diabetes who use marijuana may double their risk of developing a life-threatening complication, a new study suggests.

Researchers report connection between intestinal bacteria and development of diabetes

November 7, 2018
Researchers at Örebro University have, together with a well-known research team in Denmark, developed a method for studying how metabolism in gut bacteria influences health. Their method will now be published in its entirety ...

Genetic factors tied to obesity may protect against diabetes

November 2, 2018
Some genetic variations linked with obesity actually protect against Type 2 diabetes, heart attack and stroke, new findings suggest.

Study shows improved health, reduced overweight and obesity in Pacific-region children

October 30, 2018
A community-randomized clinical trial of the Children's Healthy Living Program (CHL), based at the University of Hawaiʻi at Mānoa, seeking to sustainably prevent and decrease overweight and obese young children and to improve ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.